On April 13, 2021, Hemanext announced that it had received CE Mark certification for Hemanext ONE® system, clearing the way for the medical device to be sold in European markets. On December 30, 2021, Hemanext submitted the Hemanext ONE® system for marketing authorization review by the U.S. Food and Drug Administration (FDA).
- Hemanext Announces Appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East, and Africa
- Impact of the Age of Blood
- Science Innovation Forum
- Hemanext Announces Partnership with Aplastic Anemia & MDS International Foundation
- Hemanext ONE Becomes First Blood Processing and Storage System to Receive Standards-Compliant Seal from AABB